date/time interval
- October 1, 2022 - March 31, 2032
Androgen Suppression Combined with Elective Nodal and a Dose Escalated Boost. A Non-Inferiority, Phase 3 Randomized Controlled Trial of Stereotactic Body Radiation Therapy versus Brachytherapy Boost (ASCENDE-SBRT)
Grant
- Overview
- Affiliation
- View All
Overview
awarded by
total award amount
- CAD 1295468